News

Correlation between Validation Master Plan and Validation Protocols

In a news item from 12 March 2025, we described deficiencies in microbiological tests of non-sterile products. However, the warning letter in question provides further information: on process validation. What was criticized?

More
FDA takes a Look at Cleaning Validation

In a recent GMP news, we pointed out deficiencies, especially regarding stability data, of an Indian manufacturer by referencing an FDA Warning Letter. This Warning Letter also offers interesting interpretation aids on the subject of cleaning validation. What is the FDA interested in?

More
Process Validation Deficits in API Manufacturing

Interpretations of legally binding requirements in the GMP environment are provided by guidelines, guidance documents, etc. (soft law) or inspection results. The following are excerpts from an FDA Warning Letter to an API manufacturer regarding process validation deficiencies. What did the FDA criticize?

More
Update of Training Material for ICH Q8, Q9 and Q10

In a detailed news article in late 2023, we referred to the new training package for the revision of the ICH Q9 guideline (quality risk management). The ICH has now published updated training material on the implementation of ICH Q8, Q9 and Q10.

More
The ICH Q9 Briefing Package - a Forgotten Document?

Due to the revision of the ICH Q9 document on quality risk management, the ICH has also published comprehensive training material on the “main text”. However, even the revised version of the ICH Q9 (R1) document still has two annexes. Training slides that the ICH published as a “Briefing Package” in 2006 are still available on the ICH website, though. Is the "Briefing Package" still up to date?

More
New FDA Guidelines: Batch Uniformity and Drug Product Integrity / Advanced Manufacturing Technologies

The U.S. Food and Drug Administration (FDA) has published two new documents: a draft guidance referred to as "Considerations for Complying with 21 CFR 211.110" and a final guidance for industry titled "Advanced Manufacturing Technologies Designation Program."

More
Qualification Deficiencies from the FDA's Perspective

There is relatively little information on the FDA's requirements for equipment qualification. A current Warning letter provides guidance.

More
Risk Analysis in Case of Insufficient Process Validation

Risk analyses are an essential prerequisite prior to process validation. But how should inadequately validated processes be handled in retrospect? The FDA comments on this in a recent Warning Letter.

More
The first GMP-Song ever?

Perhaps the first GMP song? A somewhat unusual subject. Listen to an AI generated song about equipment qualification.

More
ECA Validation Group launches redesigned Website

The ECA Validation Group website has been extensively revised. Find out what has changed and what you will find on the new ECA Foundation Group website. Enjoy browsing the new look.

More
x